Wagner, B.; Dührsen, U.; Hüttmann, A.; Nückel, H.; Michita, R.T.; Rohn, H.; Schramm, S.; Horn, P.A.; Rebmann, V.
Genetic Variants of the NKG2C/HLA-E Receptor–Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma. Cancers 2020, 12, 3429.
https://doi.org/10.3390/cancers12113429
AMA Style
Wagner B, Dührsen U, Hüttmann A, Nückel H, Michita RT, Rohn H, Schramm S, Horn PA, Rebmann V.
Genetic Variants of the NKG2C/HLA-E Receptor–Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma. Cancers. 2020; 12(11):3429.
https://doi.org/10.3390/cancers12113429
Chicago/Turabian Style
Wagner, Bettina, Ulrich Dührsen, Andreas Hüttmann, Holger Nückel, Rafael Tomoya Michita, Hana Rohn, Sabine Schramm, Peter A. Horn, and Vera Rebmann.
2020. "Genetic Variants of the NKG2C/HLA-E Receptor–Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma" Cancers 12, no. 11: 3429.
https://doi.org/10.3390/cancers12113429
APA Style
Wagner, B., Dührsen, U., Hüttmann, A., Nückel, H., Michita, R. T., Rohn, H., Schramm, S., Horn, P. A., & Rebmann, V.
(2020). Genetic Variants of the NKG2C/HLA-E Receptor–Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma. Cancers, 12(11), 3429.
https://doi.org/10.3390/cancers12113429
